PROGRESSION IN AND SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER (T3) TREATED WITH RADICAL PROSTATECTOMY AS MONOTHERAPY
作者： DIES van den OUDEN , WIM C.J. HOP , FRITZ H. SCHRODER
DOI: 10.1016/S0022-5347(01)62546-1
关键词:
摘要: AbstractPurpose: We determine the progression and survival rates in patients with locally advanced prostate cancer treated radical prostatectomy without adjuvant treatment, investigate subgroups of who may not benefit from this treatment.Materials Methods: Radical was performed 83 T3 cancer. The were divided T3G1 to 2 T3G3 tumors, which evaluated for clinical progression, local recurrence, distant metastases, biochemical overall specific at 5 10 years by Kaplan-Meier curves. results compared those 190 confined tumors.Results: At 75 60%, 85 72%, respectively. 41 69%, recurrence 18 44%, metastases 31 50%, Biochemical 71%. Patients poorly diff...
jurology.com 参考文章(25)
McHug Ta, Solomon Mh, Siders Db, Klamerus Ml, Lee F, Long-term follow-up of stages T2-T3 prostate cancer pretreated with androgen ablation therapy prior to radical prostatectomy. Anticancer Research. ,vol. 17, pp. 1507- 1510 ,(1997)
White Rd, Olsson Ca, Babayan R, Surgical management of Stage B or C prostatic carcinoma: radical surgery vs radiotherapy. Urology. ,vol. 25, pp. 30- ,(1985)
Erik T. Goluboff, Mitchell C. Benson, EXTERNAL BEAM RADIATION THERAPY DOES NOT OFFER LONG-TERM CONTROL OF PROSTATE CANCER Urologic Clinics of North America. ,vol. 23, pp. 617- 621 ,(1996) , 10.1016/S0094-0143(05)70340-2
Alan H. Yamada, Gary Lieskovsky, Zbigniew Petrovich, Su-Chiu Chen, Susan Groshen, Donald G. Skinner, Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer American Journal of Clinical Oncology. ,vol. 17, pp. 277- 285 ,(1994) , 10.1097/00000421-199408000-00001
K. Walker, Genito-urinary Surgery BMJ. ,vol. 1, pp. 140- 140 ,(1949) , 10.1136/BMJ.1.4594.140
Wim P.J. Witjes, Claude C. Schulman, Frans M.J. Debruyne, Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma Urology. ,vol. 49, pp. 65- 69 ,(1997) , 10.1016/S0090-4295(97)00171-4
William R. Morgan, Erik J. Bergstralh, Horst Zincke, Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer Urology. ,vol. 41, pp. 113- 120 ,(1993) , 10.1016/0090-4295(93)90159-8
D. van den Ouden, W.C.J. Hop, R. Kranse, F.H. Schröder, Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate BJUI. ,vol. 79, pp. 203- 211 ,(1997) , 10.1046/J.1464-410X.1997.33011.X
A. G. APRIKIAN, W. R. FAIR, V. E. REUTER, P. SOGANI, H. HERR, P. RUSSO, J. SHEINFELD, EXPERIENCE WITH NEOADJUVANT DIETHYLSTILBOESTROL AND RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER BJUI. ,vol. 74, pp. 630- 636 ,(1994) , 10.1111/J.1464-410X.1994.TB09196.X
D. OUDEN, F. M. BENTVELSEN, E. R. BOEVE, F. H. SCHRODER, Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. BJUI. ,vol. 72, pp. 489- 494 ,(1993) , 10.1111/J.1464-410X.1993.TB16183.X